Acute treatment of agitation in schizophrenia

Drug Discovery Today: Therapeutic Strategies

Volumn 8, Issue 1-2, 2011, Pages 25-29

  Zeller, Scott L ^a   Wilson, Michael P ^b  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; DIAZEPAM; DROPERIDOL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; PROMETHAZINE; RISPERIDONE; ZIPRASIDONE;

AGITATION; ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; HEALTH CARE PERSONNEL; HUMAN; RESTLESSNESS; SCHIZOPHRENIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIOLENCE;

EID: 84862175859     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2011.09.005     Document Type: Review

References (43)

1. Allen, M.H. and Currier, G.W. (2004) Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen. Hosp. Psychiatry 26, 42-49 (Pubitemid 38142566)
2. Marder, S.R. (2006) A review of agitation in mental illness: treatment guidelines and current therapies. J. Clin. Psychiatry 67 (Suppl. 10), 13-21 (Pubitemid 44433622)
3. Marco, C.A. and Vaughan, J. (2005) Emergency management of agitation in schizophrenia. Am. J. Emerg. Med. 23, 767-776 (Pubitemid 41354946)
4. Emergency Nurses Association Institute for Nursing Research: Emergency department violence surveillance study. August 2010. Available at: http://www.ena.org/IENR/Documents/ENAEDVSReportAugust2010.pdf. Accessed May 3, 2011
5. Zeller, S.L. and Rhoades, R. (2010) Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin. Ther. 32, 403-425
6. Vilke, G.M. and Wilson, M.P. (2009) Agitation: what every emergency physician should know. Emerg. Med. Rep. 30, 233-244
7. Citrome, L. (2002) Atypical antipsychotics for acute agitation. New intramuscular options offer advantages. Postgrad. Med. 112 (85-88), 94-96
8. Allen, M.H. et al. (2005) The expert consensus guideline series: treatment of behavioral emergencies 2005. J. Psychiatr. Pract. 11 (Suppl. 1), 5-108
9. Hall, R.C. et al. (1981) Unrecognized physical illness prompting psychiatric admission: a prospective study. Am. J. Psychiatry 138, 629-635 (Pubitemid 11105418)
10. Zeller, S.L. (2010) Treatment of psychiatric patients in emergency settings. Primary Psychiatry 17, 35-41
11. Fishkind, A. (2008) Agitation II: de-escalation of the aggressive patient and avoiding coercion. In Emergency Psychiatry: Principles and Practice (Glick, R.L., Berlin, A.B., Fishkind, A.B., Zeller, S.L., eds), pp. 125-136, Lippincott Williams & Wilkins
12. Holloman, G.H., Jr and Zeller, S.L. (2011) Overview of project BETA: best practices in evaluation and treatment of agitation. West. J. Emerg. Med.
13. Isbister, G.K. et al. (2010) Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study. Ann. Emerg. Med. 56, 392-401
14. Richards, J.R. and Schneir, A.B. (2003) Droperidol in the emergency department: is it safe? J. Emerg. Med. 4, 441-447 (Pubitemid 36555569)
15. Howes, O.D. and Kapur, S. (2009) The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 35, 549-562
16. Heinz, A. and Schlagenhauf, F. (2010) Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr. Bull. 36, 472-485
17. Battaglia, J. et al. (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study Am. J. Emerg. Med. 15, 335-340 (Pubitemid 27284198)
18. Raveendran, N.S. et al. (2007) Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 335, 865-872
19. Gillies, D. et al. (2005) Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst. Rev. 4, CD003079
20. Breier, A. et al. (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch. Gen. Psychiatry 59, 441-448 (Pubitemid 34477680)
21. Brook, S. et al. (2000) Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. J. Clin. Psychiatry 61, 933-941 (Pubitemid 32058009)
22. Citrome, L. (2007) Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J. Clin. Psychiatry 68, 1876-1885
23. Currier, G.W. and Simpson, G.M. (2001) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J. Clin. Psychiatry 62, 153-157 (Pubitemid 32270087)
24. Currier, G.W. et al. (2004) Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J. Clin. Psychiatry 65, 386-394
25. Hsu, W-Y. et al. (2010) Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. J. Clin. Psychopharmacol. 30, 230-234
26. Lim, H.K. et al. (2010) Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. Neuropsychobiology 62, 81-86
27. Currier, G.W. et al. (2006) A pilot, open-label study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. J. Psychiatr. Pract. 12, 223-228 (Pubitemid 44180545)
28. Warrington, L. et al. (2007) Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder. CNS Drugs 21, 835-849 (Pubitemid 47443304)
29. Marder, S.R. et al. (2010) Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. J. Clin. Psychiatry 71, 433-441
30. Wilson, M.P. et al. (2010) Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. J. Emerg. Med. [Epub ahead of print]
31. Wilson, M.P. et al. (2011) A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. J. Emerg. Med. [Epub ahead of print]
32. Dolder, C.R. and Jeste, D.V. (2003) Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol. Psychiatry 53, 1142-1145 (Pubitemid 36695090)
33. Correl, C.U. and Schenk, E.M. (2008) Tardive dyskinesia and new antipsychotics. Curr. Opin. Psychiatry 21, 151-156 (Pubitemid 351339869)
34. Satterthwaite, T.D. et al. (2008) A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation. J. Clin. Psychiatry 69, 1869-1879
35. Huf, G. et al. (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst. Rev. 3, CD005146
36. Preval, H. et al. (2005) Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen. Hosp. Psychiatry 27, 140-144 (Pubitemid 40348779)
37. Villari, V. et al. (2008) Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 405-413 (Pubitemid 351210624)
38. Zacher, L.H. and Roche-Desilets, J. (2005) Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam. J. Clin. Psychiatry 66, 1614-1615 (Pubitemid 43068709)
39. Hatta, K. et al. (2008) Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. Gen. Hosp. Psychiatry 30, 367-371 (Pubitemid 351862316)
40. Pascual, J.C. et al. (2007) Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study. Actas Esp. Psiquiatr. 35, 47-51
41. Lejeune, J. et al. (2004) Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis. Int. Clin. Psychopharmacol. 19, 259-269 (Pubitemid 39141942)
42. Lesem, M.D. et al. (2011) Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br. J. Psychiatry 198, 51-58
43. Kane, J.M. et al. (2010) Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia. J. Clin. Psychopharmacol. 30, 106-115